| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |